Ross\Johnson & Associates’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
Ross\Johnson & Associates's EXEL Position: Q3 2026 in Review
Ross\Johnson & Associates sold out of Exelixis (EXEL) in Q3 2026, closing a stake of 3 shares — an estimated $163 sold.
Ross\Johnson & Associates first reported a position in EXEL in Q1 2025 and held it in 2 quarters. The position peaked at $1.48K in Q1 2025. 775 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.
- Ross\Johnson & Associates reported no remaining Exelixis position as of Q3 2026 after selling out during the quarter.
- Ross\Johnson & Associates sold 3 Exelixis shares in Q3 2026, an estimated $163.
- Ross\Johnson & Associates first reported a position in Exelixis in Q1 2025 and held it in 2 quarters.
- Ross\Johnson & Associates's Exelixis position peaked at $1.48K in Q1 2025.
- 775 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.
Based on Ross\Johnson & Associates's 13F filing for Q3 2026, filed 16 Nov 2026.